[Azithromycin (sumamed)--in the treatment of respiratory tract infections].
作者信息
Fomina I P, Smirnova L B, Iudin S M
出版信息
Antibiot Khimioter. 1996 Feb;41(2):52-61.
PMID:8929121
Abstract
摘要
相似文献
1
[Azithromycin (sumamed)--in the treatment of respiratory tract infections].阿奇霉素（希舒美）——用于治疗呼吸道感染
Antibiot Khimioter. 1996 Feb;41(2):52-61.
2
Microbiologic activity of the newer macrolide antibiotics.新型大环内酯类抗生素的微生物活性。
Pediatr Infect Dis J. 1997 Apr;16(4):432-7. doi: 10.1097/00006454-199704000-00026.
3
Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections.阿奇霉素的特性增强了上呼吸道感染儿童的服药依从性。
Pediatr Infect Dis J. 1996 Sep;15(9 Suppl):S30-7. doi: 10.1097/00006454-199609009-00006.
4
The newer macrolides: azithromycin and clarithromycin.新型大环内酯类药物：阿奇霉素和克拉霉素。
Infect Dis Clin North Am. 2000 Jun;14(2):449-62, x. doi: 10.1016/s0891-5520(05)70257-9.
5
Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.烟草对从呼吸道感染患者分离出的生物体的抗菌筛选。
West Indian Med J. 2003 Dec;52(4):325-6.
6
Azithromycin: an interim analysis.阿奇霉素：一项中期分析。
J Int Med Res. 1991 Nov-Dec;19(6):446-50. doi: 10.1177/030006059101900603.
7
Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.阿奇霉素。对其药理特性及在呼吸道感染中作为三日疗法应用的综述。
Drugs. 1996 Mar;51(3):483-505. doi: 10.2165/00003495-199651030-00013.
8
[Pharmacokinetic and clinical evaluation of azithromycin in pediatrics].阿奇霉素在儿科的药代动力学及临床评价
Jpn J Antibiot. 1996 Nov;49(11):994-1003.
9
Introduction: revolutionary changes in the macrolide and azalide antibiotics.
Am J Med. 1991 Sep 12;91(3A):1S-4S. doi: 10.1016/0002-9343(91)90393-c.
10
[Five years of sumamed on Russian market].
Antibiot Khimioter. 1997;42(11):42-4.
Zotero 插件